B. Kadesjö

发表

Omega-3/Omega-6 Fatty Acids for Attention Deficit Hyperactivity Disorder

C. Gillberg, Mats Johnson, S. Östlund, 2009, Journal of attention disorders.

Fatty acids in ADHD: plasma profiles in a placebo-controlled study of Omega 3/6 fatty acids in children and adolescents

B. Areskoug, C. Gillberg, Mats Johnson, 2012, ADHD Attention Deficit and Hyperactivity Disorders.

Developmental coordination disorder in Swedish 7-year-old children.

C. Gillberg, B. Kadesjö, C. Gillberg, 1999, Journal of the American Academy of Child and Adolescent Psychiatry.

Neuropsychiatric and neurodevelopmental outcome of children at age 6 and 7 years who screened positive for language problems at 30 months

Christopher Gillberg, Carmela Miniscalco, C. Gillberg, 2006, Developmental medicine and child neurology.

Development problems were common five years after positive screening for language disorders and, or, autism at 2.5 years of age

C. Gillberg, E. Fernell, B. Kadesjö, 2018, Acta paediatrica.

The FTF (Five to Fifteen): the development of a parent questionnaire for the assessment of ADHD and comorbid conditions

C. Gillberg, B. Kadesjö, M. Korkman, 2004, European Child & Adolescent Psychiatry.

Attention-deficit-hyperactivity disorder with and without oppositional defiant disorder in 3- to 7-year-old children.

C. Gillberg, B. Kadesjö, B. Hägglöf, 2003, Developmental medicine and child neurology.

Routine developmental screening at 5.5 and 7 years of age is not an efficient predictor of attention deficit hyperactivity disorder – a critical comment

B. Kadesjö, 2009, Acta paediatrica.

ADHD and the QbTest: Diagnostic Validity of QbTest

C. Gillberg, B. Kadesjö, E. Billstedt, 2018, Journal of attention disorders.

Attention deficits and clumsiness in Swedish 7‐year‐old children

C. Gillberg, B. Kadesjö, 1998, Developmental medicine and child neurology.

Co–existing disorders in ADHD – implications for diagnosis and intervention

C. Gillberg, A. Rothenberger, C. Gillberg, 2004, European Child & Adolescent Psychiatry.

Attention‐deficit/hyperactivity disorder with oppositional defiant disorder in Swedish children – an open study of collaborative problem solving

C. Gillberg, E. Fernell, Mats Johnson, 2012, Acta paediatrica.

The comorbidity of ADHD in the general population of Swedish school-age children.

C. Gillberg, C. Gillberg, B. Kadesjö, 2001, Journal of child psychology and psychiatry, and allied disciplines.

Efficacy and safety of atomoxetine as add-on to psychoeducation in the treatment of attention deficit/hyperactivity disorder

P. Svanborg, B. Kadesjö, P. Gustafsson, 2009, European Child & Adolescent Psychiatry.

The Autism - Tics, AD/HD and other Comorbidities inventory (A-TAC): further validation of a telephone interview for epidemiological research

Christopher Gillberg, Maria Råstam, Henrik Anckarsäter, 2010, BMC psychiatry.

Atomoxetine improves patient and family coping in attention deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled study in Swedish children and adolescents

P. Svanborg, B. Kadesjö, P. Gustafsson, 2009, European Child & Adolescent Psychiatry.

ADHD in Swedish 3- to 7-year-old children.

C. Gillberg, B. Kadesjö, C Gillberg, 2001, Journal of the American Academy of Child and Adolescent Psychiatry.

Negotiating knowledge: parents' experience of the neuropsychiatric diagnostic process for children with autism.

Katja Laakso, B. Kadesjö, E. Carlsson, 2016, International journal of language & communication disorders.

Why Bother About Clumsiness? The Implications of Having Developmental Coordination Disorder (DCD)

C. Gillberg, B. Kadesjö, 2003, Neural plasticity.

Tourette's disorder: epidemiology and comorbidity in primary school children.

C. Gillberg, C. Gillberg, B. Kadesjö, 2000, Journal of the American Academy of Child and Adolescent Psychiatry.

Gender differences on the Five to Fifteen questionnaire in a non-referred sample with inattention and hyperactivity-impulsivity and a clinic-referred sample with hyperkinetic disorder.

B. Kadesjö, R. Lambek, A. Trillingsgaard, 2010, Scandinavian journal of psychology.

Neuropsychiatric and neurodevelopmental disorders in a young school-age population. Epidemiology and comorbidity in a school health perspective

B. Kadesjö, 2000 .

Neurodevelopmental problems and quality of life in 6‐year‐olds with a history of developmental language disorder

C. Gillberg, B. Kadesjö, C. Miniscalco, 2021, Acta paediatrica.

Brief Report: Autism and Asperger Syndrome in Seven-Year-Old Children: A Total Population Study

B Hagberg, C. Gillberg, B. Kadesjö, 1999, Journal of autism and developmental disorders.

Using the five to fifteen-collateral informant questionnaire for retrospective assessment of childhood symptoms in adults with and without autism or ADHD

C. Gillberg, T. Hirvikoski, S. Lajic, 2020, European Child & Adolescent Psychiatry.

Children screening positive for language delay at 2.5 years: language disorder and developmental profiles

C. Gillberg, B. Kadesjö, C. Miniscalco, 2018, Neuropsychiatric disease and treatment.

Narrative skills, cognitive profiles and neuropsychiatric disorders in 7-8-year-old children with late developing language.

Christopher Gillberg, Carmela Miniscalco, C. Gillberg, 2007, International journal of language & communication disorders.

Developmental coordination disorder in Swedish 7-year-old children.

C. Gillberg, B. Kadesjö, 1999, Journal of the American Academy of Child and Adolescent Psychiatry.

Children screening positive for language delay at 2.5 years: language disorder and developmental profiles

C. Gillberg, B. Kadesjö, C. Miniscalco, 2018, Neuropsychiatric disease and treatment.

children screening positive for language delay at 2.5 years: language disorder and developmental profiles

B. Kadesjö, C. Miniscalco, -. Ulrikaschachinger, 2018 .

Efficacy and safety of atomoxetine as add-on to psychoeducation in the treatment of attention deficit/hyperactivity disorder

P. Svanborg, B. Kadesjö, P. Gustafsson, 2009, European Child & Adolescent Psychiatry.

Placebo-Controlled Trial in Children and Adolescents Omega-3/Omega-6 Fatty Acids for Attention Deficit Hyperactivity Disorder : A Randomized

B. Areskoug, S. Östlund, Gunnar Fransson, 2022 .